Unlikely that high cholesterol or medication for it increase the risk of dementia

Over 600,000 people in Norway take cholesterol-lowering medicines on prescription. The majority of these drugs are called statins. But not all these patients actually take their medicine.

Professor and chief physician Kjetil Retterstøl at the Institute of Basic Medical Sciences at the University of Oslo frequently hears that patients have stopped taking statins without first consulting their doctor.

"Many fear side effects because they read reports in the media that make them afraid. Some are concerned about how the drugs will affect their mental health if they take them over a long period of time. Others feel that statins are the cause of muscle pain and problems with sleeping. These symptoms may be due to side effects, but it is also probable that these patients are at an age when health problems of this kind are more likely to arise in any case," he explains.

British study: high cholesterol is associated with an increased risk of dementia

A question many people ask is: can a long-term intake of statins increase the risk of other disorders such as dementia? But what is associated with what? Is it the level of cholesterol, the statins or an unhealthy lifestyle that lead to an increased risk of dementia?

A major British study involving 1.8 million people concluded that an elevated level of cholesterol appeared to be linked to an increased risk of developing dementia. The study was published in The Lancet Healthy Longevity in 2021.

People with hereditary high cholesterol eating a healthy diet have no increased risk of dementia

In a new study, Retterstøl and his colleagues came to a different conclusion than that of the British scientists. In his opinion, neither cholesterol itself nor statins can explain an increased risk of developing dementia. The real reason may be that lifestyle habits lead to high cholesterol.

Their research involved a more thorough study of the health of people with hereditary high cholesterol. These patients’ high cholesterol is not caused by their lifestyle and by and large, they do not eat unhealthily. Instead, their high cholesterol is genetic. The scientists also took into account whether the participants in the study were taking a high or low dose of statins.

"In Norway, we have good health registries that we can link our research data to. We were therefore able to look at data relating to over 3,500 people with hereditary high cholesterol and find out how many of them were diagnosed with dementia. We followed this group for a period of over 10 years but found no increased risk of dementia compared to our control group of almost 70,000. We didn’t find any difference between those taking a high or a low dose of statins either," Retterstøl says.

If you put off taking statins, you will benefit less from them later on

High cholesterol is often called a silent killer because it does not manifest itself through symptoms. Retterstøl points out that the trouble with taking statins is that the patient will not notice any physical improvement. In the same way, they don’t notice any difference if they stop taking the medicine.

But the absence of the medicine means that harmful processes can carry on unnoticed in the body and cholesterol plaque builds up in the arteries, resulting in a possible heart attack or stroke.

"A third of the population dies of cardiovascular disorders and it is particularly sad when young people are affected. If you decide to postpone taking statins, the benefit will be less when you do start taking them. Nobody wants to take pills, but doing so is an investment in your future good health," says the professor.

Consult your doctor if you experience side effects from statins

If you are taking statins and experience muscle pain or difficulty in sleeping, Retterstøl has the following advice:

"Don’t stop taking the statins without first talking to your doctor. Often in such cases, we ask the patient to stop taking the statins for a short while in order to check whether it is really the medicine that is the source of the side effects. If the patient then tells us that there is an improvement, we ask them to start taking the medicine again for a period to see if the symptoms return. If this is the case, the type and dosage of the statins can be changed."

The group of scientists behind the study consists of researchers at Oslo University Hospital, the University of Bergen, the Western Norway University of Applied Sciences and the University of Oslo.

Reference:

Iwagami et al. Blood cholesterol and risk of dementia in more than 1.8 million people over two decades: a retrospective cohort study, The Lancet Healthy Longevity, 2021. DOI: 10.1016/S2666-7568(21)00150-1

Mundal et al. Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway, JAMA Network Open, 2022. DOI: 10.1001/jamanetworkopen.2022.7715

This article/press release is paid for and presented by the University of Oslo

This content is created by the University of Oslo's communication staff, who use this platform to communicate science and share results from research with the public. The University of Oslo is one of more than 80 owners of ScienceNorway.no. Read more here.

See more content from the University of Oslo:

• 

  New method tested on mice gives new hope for immunotherapy against prostate cancer

• 

  Envisioning a radically different future makes us more prepared

• 

  Some subsidies are counterproductive

• 

  Music can repair some of the damage inflicted by a prison sentence

• 

  Researchers believe that Uncle Tom's Cabin in Norwegian reflects the evolution of the racism debate

• 

  Why kindergarten matters for children growing up in poor families